Arcus Biosciences Inc. (RCUS) Declined -7.93% or -0.84 To Price $9.75 On Thursday


Arcus Biosciences Inc. (RCUS) declined -7.93% or -0.84 to $9.75. It is about 242870 shares traded, which is 78.05% compare to the average total volume 311190. The market cap of RCUS is $433.42 million. The year to date change is -45.64%. The 52 week price range is from $9.17 to $22.1. Price of RCUS have changed -1.94% during last week. It have changed -5.95% over last month, -23.54% over last 3 months, -25.53% over last 6 months and -37.71% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for RCUS is 11.45. It is 17.44% above current price. The 200-day Moving Averages for RCUS is 13.64. It is 39.90% above current price. The 52-week High is 22.1. It is 126.67% from the current price. The 52-week Low is 9.17. It is -5.95% from current price.

Some people may be interesting about short interest ratio of a stock. The short interest ratio of RCUS is 4.2 on 2018-11-30. Short % to float is 2.01%. There are some statistics of RCUS. It is has market cap $433.42 million. The share outstanding is 44.45 million. The average volume is 311190. The percent of top 15 Institution holding is 43.50%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of RCUS is -20.61%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of RCUS is -17.62%.


Tags:

Share this post